Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A, Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)

NCT02211560 is registered in ClinicalTrials.gov with Enzymotec as lead sponsor.

NCT NCT02211560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02211560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A, Multi-center, Double-blind, Randomized, Placebo-controlled Study for the Efficacy of Phosphatidylserine in Mild Cognitive Impairment (MCI)
Lead sponsor
Enzymotec
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2014
Completion date
December 25, 2017
Enrollment
97 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment